L. Miao

机构：Nanjing Drum Tower Hospital · ORCID：0009-0009-4007-5908

发表论文 4 篇 · 总被引 10 次 · h-index 2

代表论文

• 77P A study to evaluate the safety, tolerability and efficacy of IBI939 in combination with sintilimab in patients with previously untreated locally advanced unresectable or metastatic PD-L1-selected non-small cell lung cancer (NSCLC) (2022 · Immuno-Oncology Technology · 被引 5)
• LBA58 Sintilimab with or without IBI305 plus chemotherapy in patients with EGFR mutated non-squamous non-small cell lung cancer (EGFRm nsqNSCLC) who progressed on EGFR tyrosine-kinase inhibitors (TKIs) therapy: Second interim analysis of phase III ORIENT-31 study (2022 · Annals of Oncology · 被引 4)
• Objective Neurological Testing Methods Used to Follow Up Vestibular Neuritis Depending on Different Factors (2023 · International Journal of General Medicine · 被引 1)
• 68P: Survival impact of immunotherapy(IO) after chemo-failure in EGFR-mutated NSCLCA post-hoc analysis of the Orient-31 trial (2025 · Journal of Thoracic Oncology)